Skip to search formSkip to main contentSkip to account menu

azetepa

Known as: Phosphinic amide, P,P-bis(1-aziridinyl)-N-ethyl-N-1,3,4-thiadiazol-2-yl-, thiatriamide 
An azirine-based thiotepa derivative with alkylating activity. Azetepa is able to alkylate and crosslink DNA, causing DNA damages and eventually an… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AzirinesNSC-64826

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1967
1967
Intra-articular use of cytostatica. (Thio-Tepa, Azetepa and Osmium acid).
Summary39 patients, of which 32 had rheumatoid arthritis, were treated with Thio-Tepa (27), Azetepa (7) and osmium acid (5… 
1965
1965
“AZETEPA”: A NEW ALKYLATING AGENT
Over a period of 18 months, I have treated 22 patients with "Azetepa" by oral administration in a maintenance course of 10 to 30… 
1965
1965
"AZETEPA": A NEW ALKYLATING AGENT.
1964
1964
AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER.
1964
1964
CLINICAL STUDIES WITH AZETEPA IN THE TREATMENT OF ADVANCED CANCER.
1964
1964
CLINICAL STUDIES WITH AZETEPA IN THE TREATMENT OF ADVANCED CANCER.
  • J. Bateman
  • Acta - Unio Internationalis Contra Cancrum
  • 1964
  • Corpus ID: 38407789
1962
1962
Clinical experience with a new alkylating agent, azetepa, in a variety of solid tumors.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)